
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    As a professional computational biologist, I will meticulously analyze the provided ranked marker list from a single-cell RNA sequencing dataset originating from human large intestine tissue to identify the cell type. I will follow a step-by-step approach, providing detailed reasoning for each inference.<br><br>**Input Marker List (ranked by expression intensity, high to low):**<br>GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8<br><br>---<br><br>**1. List the Key Functional Markers:**<br><br>This step focuses on genes that indicate specific biological processes, pathways, or secreted products.<br><br>*   **GCG (Glucagon):** Encodes proglucagon, which is processed into glucagon, a hormone primarily known for regulating glucose homeostasis. In the intestine, proglucagon can also be processed into GLP-1, GLP-2, and oxyntomodulin, which have roles in satiety, gut growth, and glucose regulation.<br>*   **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** A proprotein convertase involved in the proteolytic processing of many prohormones and proneuropeptides, including proglucagon, proinsulin, and proopiomelanocortin. Its presence is crucial for the maturation of peptide hormones.<br>*   **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone (CRH) family. It plays roles in stress response, appetite regulation, and gastrointestinal motility.<br>*   **PYY (Peptide YY):** A peptide hormone secreted by enteroendocrine cells in the gut in response to food intake. It reduces appetite and inhibits gastrointestinal motility.<br>*   **INSL5 (Insulin-like 5):** A peptide hormone primarily expressed in enteroendocrine cells of the colon and rectum. It is involved in regulating colonic motility and has been linked to appetite regulation.<br>*   **CHGA (Chromogranin A):** A major soluble protein co-stored and co-released with peptide hormones and neurotransmitters from neuroendocrine cells. It is a general marker for neuroendocrine differentiation.<br>*   **SCG2 (Secretogranin II):** Another member of the chromogranin/secretogranin family, involved in the regulated secretion of peptide hormones and neuropeptides.<br>*   **SCGN (Secretagogin):** A calcium-binding protein expressed in neuroendocrine cells, involved in exocytosis and hormone secretion.<br>*   **SLC18A1 (Solute Carrier Family 18 Member A1, Vesicular Monoamine Transporter 1 - VMAT1):** Transports monoamines (like serotonin, dopamine, norepinephrine) into synaptic vesicles or dense-core granules for regulated release. Crucial for neuroendocrine cells that secrete monoamines.<br>*   **SCG3 (Secretogranin III):** Similar to SCG2, involved in neuroendocrine secretion.<br>*   **SCG5 (Secretogranin V, Neurosecretory Protein VGF):** A neuropeptide precursor involved in energy homeostasis, metabolism, and neurogenesis.<br>*   **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in the biosynthesis of serotonin (5-hydroxytryptamine, 5-HT). In the gut, TPH1 is highly expressed in enterochromaffin (EC) cells, which are a type of enteroendocrine cell.<br>*   **SNAP25 (Synaptosomal-Associated Protein, 25 kDa):** A component of the SNARE complex, essential for vesicle fusion and neurotransmitter/hormone release. Widely expressed in neurons and neuroendocrine cells.<br>*   **CHGB (Chromogranin B):** Another member of the chromogranin family, similar to CHGA, indicating neuroendocrine differentiation and regulated secretion.<br>*   **SLC32A1 (Solute Carrier Family 32 Member A1, Vesicular GABA Transporter - VGAT):** Transports GABA and glycine into synaptic vesicles. While primarily neuronal, its presence in neuroendocrine cells can indicate specific signaling pathways.<br>*   **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes SUR1, a subunit of the ATP-sensitive potassium channel (KATP channel). KATP channels are crucial in pancreatic beta cells for glucose-stimulated insulin secretion, and similar mechanisms can be found in other hormone-secreting cells.<br>*   **SCT (Secretin):** A peptide hormone secreted by S cells in the duodenum in response to acidic chyme. It stimulates bicarbonate secretion from the pancreas and bile ducts. While primarily duodenal, its presence suggests enteroendocrine function.<br>*   **ARX (Aristaless Related Homeobox):** A transcription factor crucial for the development and differentiation of various cell types, including pancreatic alpha cells and certain enteroendocrine cells.<br>*   **SLC5A8 (Solute Carrier Family 5 Member 8, Sodium-coupled monocarboxylate transporter 1 - SMCT1):** Transports short-chain fatty acids (SCFAs) and monocarboxylates. SCFAs are important signaling molecules in the gut, and their uptake can be relevant for certain enteroendocrine cell functions or nutrient sensing.<br><br>**Summary of Functional Markers:** The overwhelming presence of genes involved in peptide hormone synthesis (GCG, PYY, INSL5, UCN3, SCT), processing (PCSK1), storage (CHGA, CHGB, SCG2, SCG3, SCG5), and regulated secretion (SNAP25, SCGN, SLC18A1, ABCC8) strongly points towards a secretory cell type, specifically one involved in neuroendocrine signaling. The presence of TPH1 further refines this to cells capable of serotonin synthesis.<br><br>---<br><br>**2. List the Key Cell Type Markers:**<br><br>This step focuses on genes known to be specific markers for particular cell types within the large intestine or broader gastrointestinal tract.<br><br>*   **GCG (Glucagon):** While a functional marker, it is also a key marker for L-cells (a type of enteroendocrine cell) in the intestine, where it is processed into GLP-1, GLP-2, and oxyntomodulin.<br>*   **PYY (Peptide YY):** A definitive marker for L-cells.<br>*   **INSL5 (Insulin-like 5):** A specific marker for L-cells, particularly in the colon and rectum.<br>*   **UCN3 (Urocortin 3):** Expressed in a subset of enteroendocrine cells, including some L-cells.<br>*   **CHGA (Chromogranin A):** A pan-neuroendocrine marker, indicating the general class of cells.<br>*   **NKX2-2 (NK2 Homeobox 2):** A transcription factor involved in the development and differentiation of various neuroendocrine cell types, including pancreatic alpha and beta cells, and some enteroendocrine cells. Its presence suggests a committed neuroendocrine lineage.<br>*   **FEV (Fez family zinc finger 2):** A transcription factor expressed in specific enteroendocrine cell types, including L-cells and EC cells.<br>*   **INSM1 (Insulinoma-associated protein 1):** A crucial transcription factor for neuroendocrine differentiation and development. It is a pan-neuroendocrine marker.<br>*   **RFX6 (Regulatory Factor X6):** A transcription factor essential for the development and differentiation of various enteroendocrine cell types, including L-cells, K-cells, and S-cells.<br>*   **SCT (Secretin):** A specific marker for S-cells, a type of enteroendocrine cell primarily found in the duodenum. Its presence here, though less prominent than L-cell markers, suggests some overlap or a broader enteroendocrine population.<br>*   **TPH1 (Tryptophan Hydroxylase 1):** A specific marker for enterochromaffin (EC) cells, which are the most abundant enteroendocrine cell type in the gut and primarily secrete serotonin.<br>*   **ARX (Aristaless Related Homeobox):** As mentioned, a transcription factor important for enteroendocrine cell development, including L-cells.<br><br>**Summary of Cell Type Markers:** The co-expression of GCG, PYY, INSL5, UCN3, FEV, NKX2-2, INSM1, RFX6, and TPH1 is highly characteristic of enteroendocrine cells. The strong presence of GCG, PYY, and INSL5 points specifically towards L-cells, while TPH1 indicates the presence of EC cells. The transcription factors (NKX2-2, FEV, INSM1, RFX6, ARX) further confirm a committed neuroendocrine lineage.<br><br>---<br><br>**3. Cross-reference Known Databases:**<br><br>I will mentally cross-reference these markers with established single-cell RNA-seq atlases and literature on intestinal cell types.<br><br>*   **Human Cell Atlas (HCA) / Tabula Sapiens:** These resources consistently show GCG, PYY, INSL5, CHGA, CHGB, PCSK1, SCG2, SCGN, TPH1, INSM1, RFX6, NKX2-2, and ARX as defining markers for various enteroendocrine cell (EEC) subtypes in the gut.<br>*   **Specific Gut scRNA-seq Studies:** Numerous publications on intestinal scRNA-seq (e.g., from the labs of Hans Clevers, Jeffrey Gordon, etc.) confirm that the co-expression of GCG, PYY, and INSL5 is a hallmark of L-cells, while TPH1 is specific to EC cells. Pan-neuroendocrine markers like CHGA, CHGB, PCSK1, and INSM1 are universally present in EECs.<br>*   **Gene Ontology (GO) and KEGG Pathways:** Searching these databases for the top markers would confirm their involvement in "peptide hormone secretion," "neuroendocrine differentiation," and "monoamine biosynthesis."<br><br>The marker list is highly consistent with known enteroendocrine cell populations in the large intestine.<br><br>---<br><br>**4. Determine the Most Probable General Cell Type:**<br><br>Based on the comprehensive analysis of both functional and cell-type specific markers, the most probable general cell type is **Enteroendocrine Cells (EECs)**.<br><br>**Reasoning:**<br>*   **Abundance of Hormone-Related Genes:** The top markers are overwhelmingly involved in the synthesis, processing, storage, and secretion of peptide hormones (GCG, PYY, INSL5, UCN3, SCT) and monoamines (TPH1, SLC18A1).<br>*   **Pan-Neuroendocrine Markers:** The presence of CHGA, CHGB, PCSK1, SCG2, SCGN, SCG3, SCG5, SNAP25, and INSM1 are classic indicators of neuroendocrine differentiation.<br>*   **Key Transcription Factors:** NKX2-2, FEV, RFX6, and ARX are well-established regulators of enteroendocrine cell development and identity.<br>*   **Tissue Context:** In the large intestine, these markers are uniquely expressed by enteroendocrine cells, which are specialized epithelial cells interspersed within the intestinal lining.<br><br>---<br><br>**5. Identify the Top 3 Most Probable Sub Cell Types:**<br><br>Within the general category of Enteroendocrine Cells, several subtypes exist, each characterized by a unique hormone profile.<br><br>1.  **Most Likely Subtype: L-cells (Glucagon-like peptide-1/2, Peptide YY, Insulin-like 5 secreting cells)**<br>    *   **Strongest Evidence:** The highest expressed specific markers are **GCG**, **PYY**, and **INSL5**. These three genes are the defining markers for L-cells, particularly in the large intestine. GCG is processed into GLP-1 and GLP-2 in intestinal L-cells, not glucagon. The high expression of PCSK1 is also critical for this processing. UCN3 is also known to be expressed in a subset of L-cells.<br>    *   **Supporting Markers:** Pan-neuroendocrine markers (CHGA, PCSK1, SCG2, SCGN, SNAP25, CHGB, INSM1) are consistent with L-cell identity. Transcription factors like NKX2-2, FEV, RFX6, and ARX are known to regulate L-cell development.<br><br>2.  **Second Most Likely Subtype: EC-cells (Enterochromaffin cells - Serotonin secreting cells)**<br>    *   **Strong Evidence:** The presence of **TPH1** (Tryptophan Hydroxylase 1) is the definitive marker for EC cells, as it is the rate-limiting enzyme for serotonin synthesis. **SLC18A1 (VMAT1)**, which packages serotonin into vesicles, also supports this.<br>    *   **Consideration:** While TPH1 is present, it appears lower in the ranked list compared to the L-cell specific markers (GCG, PYY, INSL5). This suggests that while EC cells are likely present, they might be a smaller proportion of this cluster, or the L-cell signature is dominant. However, EC cells are the most abundant EEC type in the gut. The ranking suggests a strong L-cell signature.<br><br>3.  **Third Most Likely Subtype: S-cells (Secretin secreting cells)**<br>    *   **Evidence:** The presence of **SCT (Secretin)**, albeit lower in the ranked list, indicates the potential presence of S-cells.<br>    *   **Consideration:** S-cells are primarily found in the duodenum and jejunum, with very few in the large intestine. Their presence here would be minor or represent a rare population. The high expression of L-cell markers makes S-cells a less dominant component of this cluster.<br><br>**Most Likely Subtype based on markers:**<br>Given the very high expression of **GCG, PYY, and INSL5**, the most likely specific subtype is **L-cells**. The cluster appears to be highly enriched for L-cell markers, with a secondary, but still significant, signature of EC cells (TPH1). It is common for enteroendocrine cell clusters to show some degree of co-expression of markers from different subtypes, or to represent a continuum of differentiation, but the dominant signature here is clearly L-cell.<br><br>---<br><br>**6. Provide a Concise Summary of Your Analysis:**<br><br>The single-cell cluster from human large intestine tissue is definitively identified as **Enteroendocrine Cells (EECs)**. This annotation is strongly supported by the high expression of numerous pan-neuroendocrine markers (e.g., CHGA, PCSK1, SCG2, SCGN, SNAP25, INSM1) and key transcription factors (e.g., NKX2-2, FEV, RFX6, ARX) involved in neuroendocrine differentiation and hormone secretion.<br><br>Within the enteroendocrine cell population, the most prominent and highly expressed specific markers are **GCG, PYY, and INSL5**. These genes are the defining hallmarks of **L-cells**, which are a major subtype of EECs in the large intestine, responsible for secreting GLP-1, GLP-2, and Peptide YY, hormones crucial for glucose homeostasis, satiety, and gut motility.<br><br>A secondary, but notable, signature is the presence of **TPH1** and **SLC18A1**, indicating the likely presence of **Enterochromaffin (EC) cells**, which are the primary source of serotonin in the gut. The lower ranking of TPH1 compared to L-cell markers suggests that L-cells are the dominant population within this cluster. The presence of SCT suggests a minor contribution from S-cells, though these are rare in the large intestine.<br><br>Therefore, this cluster represents a population of **Enteroendocrine Cells, highly enriched for L-cells, with a significant contribution from EC cells.**<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                    <div class="agent-section formatting">
                        <h2>üìã Summary</h2>
                        <p class="error-message">Error formatting data: Expecting value: line 1 column 1 (char 0)</p>
                    </div>
                
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">98</div>
                        <div class="scoring-content">
                            The annotation provided is exceptionally thorough and accurate, demonstrating a deep understanding of single-cell RNA sequencing data analysis and gastrointestinal biology.<br><br>**Strengths:**<br><br>1.  **Comprehensive Marker Analysis:** The agent meticulously lists and explains both functional and cell-type specific markers. This two-pronged approach provides a robust foundation for the annotation.<br>2.  **Detailed Justification:** Each step of the reasoning is clearly articulated, explaining why certain markers are significant and how they contribute to the overall cell type identification. This transparency is excellent for understanding the decision-making process.<br>3.  **Consideration of Marker Ranking:** The agent explicitly acknowledges the ranking of markers (high to low expression intensity), which is crucial for identifying dominant cell signatures within a cluster. This is evident in the emphasis on GCG, PYY, and INSL5 for L-cells, and the recognition that TPH1's lower rank suggests EC cells might be a smaller proportion, despite being the most abundant EEC type overall.<br>4.  **Biological Context Integration:** The annotation effectively integrates knowledge about the human large intestine, such as the primary locations of S-cells (duodenum/jejunum) versus L-cells (large intestine), which enhances the accuracy of the sub-cell type predictions.<br>5.  **Pan-Neuroendocrine Recognition:** The identification of pan-neuroendocrine markers (CHGA, CHGB, PCSK1, SCG2, SCGN, SNAP25, INSM1) and key transcription factors (NKX2-2, FEV, RFX6, ARX) as indicators of a general neuroendocrine lineage is spot on.<br>6.  **Accurate Subtype Differentiation:** The clear distinction and prioritization of L-cells and EC-cells based on the marker profile are highly accurate. The nuanced discussion of S-cells, acknowledging their presence but downplaying their significance due to tissue context and lower marker ranking, is also well-reasoned.<br>7.  **Addressing Potential Mixed Populations:** The conclusion that the cluster is "highly enriched for L-cells, with a significant contribution from EC cells" accurately captures the likely mixed nature of the cluster, which is common in single-cell data where closely related cell types can cluster together.<br>8.  **Cross-referencing with Databases:** The mention of cross-referencing with HCA, Tabula Sapiens, and specific scRNA-seq studies adds significant credibility and validates the findings against established knowledge.<br><br>**Weaknesses (Minor, more like potential areas for even further refinement):**<br><br>1.  **AC090679.1, AL133325.3, C1orf127, LINC01014, AL161658.1, AP003062.3:** While the focus is rightly on well-known functional and cell-type specific markers, the presence of several uncharacterized or non-coding RNA genes (AC090679.1, AL133325.3, C1orf127, LINC01014, AL161658.1, AP003062.3) in the top markers could have been briefly acknowledged, even if just to state that their specific function in this context is unknown or that they are likely co-expressed. However, given the strong signal from known genes, omitting detailed analysis of these is a pragmatic decision.<br>2.  **COL2A1 (Collagen Type II Alpha 1 Chain):** This gene is typically associated with cartilage and connective tissue. Its presence, even lower down on the list, is somewhat anomalous for an enteroendocrine cell cluster. While it could be noise, or a very minor contaminant, a brief comment on its unexpected appearance might have been warranted, especially if it's not a known marker for any EEC subset. However, given its low rank, the agent correctly prioritizes the strong neuroendocrine signals.<br><br>Overall, the analysis is exemplary. It correctly identifies the cell type, provides robust evidence, and handles the complexities of subtype identification with nuance and biological accuracy. The thought process is logical and very well-explained.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    